Figure 3.
Mean (A) frequency and (B) severity of moderate and severe VMS during the 52-week treatment period (FAS and FAS-fezolinetant exposure). Abbreviations: FAS, full analysis set; VMS, vasomotor symptoms.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.